91 related articles for article (PubMed ID: 44694)
1. Clinical evidence for multiple dopamine receptors in man.
Meltzer HY
Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
[No Abstract] [Full Text] [Related]
2. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
3. Further evidence for the existence of multiple receptors for dopamine in the central nervous system.
Iversen LL; Quik M; Emson PC; Dowling JE; Watling KJ
Adv Biochem Psychopharmacol; 1980; 21():193-202. PubMed ID: 6103646
[No Abstract] [Full Text] [Related]
4. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
5. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
6. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
Clement-Cormier Y
Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
[No Abstract] [Full Text] [Related]
7. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
8. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
9. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
[No Abstract] [Full Text] [Related]
10. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
Hyttel J
Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
[No Abstract] [Full Text] [Related]
11. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system dopamine receptors.
Creese I
Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
[No Abstract] [Full Text] [Related]
14. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
Weiss B; Levin RM
Adv Cyclic Nucleotide Res; 1978; 9():285-303. PubMed ID: 27079
[No Abstract] [Full Text] [Related]
15. [The pharmacologist facing the neuroleptics].
Costentin J
Encephale; 1991 Jun; 17 Spec No 2():153-7. PubMed ID: 1677889
[No Abstract] [Full Text] [Related]
16. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
Borison RL; Fields JZ; Diamond BI
Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
[No Abstract] [Full Text] [Related]
17. Schizophrenia.
Bladessarini RJ
N Engl J Med; 1977 Nov; 297(18):988-95. PubMed ID: 20577
[No Abstract] [Full Text] [Related]
18. Optic tectum adenylate cyclase activity from goldfish (Carassius auratus) as a model to assess dopamine receptor agonists and antagonists.
De Sarro A; De Gori N; Urna G; Pujia A; Nistico' G
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):241-9. PubMed ID: 6133329
[TBL] [Abstract][Full Text] [Related]
19. Behavioral pharmacologic studies in the monkey with DD-3480.
Shibuya T; Nishimori T; Matsuda H; Chen PC
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
[TBL] [Abstract][Full Text] [Related]
20. Chemistry of dopamine receptors.
Kebabian JW; Clement-Cormier YC; Petzold GL; Greengard P
Adv Neurol; 1975; 9():1-11. PubMed ID: 238374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
